Skip to content
PICO Portalanswers from OpenAlex

The <i>BRAF</i> mutation is useful for prediction of clinical recurrence in low‐risk patients with conventional papillary thyroid carcinoma

PaperCitations, authors & open-access status

The <i>BRAF</i> mutation is useful for prediction of clinical recurrence in low‐risk patients with conventional papillary thyroid carcinoma is a paper indexed in PICO Portal from OpenAlex.

How many citations does The <i>BRAF</i> mutation is useful for prediction of clinical recurrence in low‐risk patients with conventional papillary thyroid carcinoma have?

PICO Portalcitation count

The <i>BRAF</i> mutation is useful for prediction of clinical recurrence in low‐risk patients with conventional papillary thyroid carcinoma has 240 citations in the OpenAlex counts PICO Portal stores.

When was The <i>BRAF</i> mutation is useful for prediction of clinical recurrence in low‐risk patients with conventional papillary thyroid carcinoma published?

PICO Portalyear

The <i>BRAF</i> mutation is useful for prediction of clinical recurrence in low‐risk patients with conventional papillary thyroid carcinoma has 2006 year in the PICO Portal index.

What is the open-access status of The <i>BRAF</i> mutation is useful for prediction of clinical recurrence in low‐risk patients with conventional papillary thyroid carcinoma?

PICO Portaloa status

The <i>BRAF</i> mutation is useful for prediction of clinical recurrence in low‐risk patients with conventional papillary thyroid carcinoma has closed oa status in the PICO Portal index.

What is the DOI of The <i>BRAF</i> mutation is useful for prediction of clinical recurrence in low‐risk patients with conventional papillary thyroid carcinoma?

PICO Portaldoi

The DOI for The <i>BRAF</i> mutation is useful for prediction of clinical recurrence in low‐risk patients with conventional papillary thyroid carcinoma is on the source record.

What is the PMID of The <i>BRAF</i> mutation is useful for prediction of clinical recurrence in low‐risk patients with conventional papillary thyroid carcinoma?

PICO Portalpmid

The PMID for The <i>BRAF</i> mutation is useful for prediction of clinical recurrence in low‐risk patients with conventional papillary thyroid carcinoma is on the source record.

What is the OpenAlex record for The <i>BRAF</i> mutation is useful for prediction of clinical recurrence in low‐risk patients with conventional papillary thyroid carcinoma?

PICO Portalopenalex

The OpenAlex for The <i>BRAF</i> mutation is useful for prediction of clinical recurrence in low‐risk patients with conventional papillary thyroid carcinoma is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial